These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2308469)

  • 1. Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.
    Ohta S; Tachikawa O; Makino Y; Tasaki Y; Hirobe M
    Life Sci; 1990; 46(8):599-605. PubMed ID: 2308469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tetrahydroisoquinolines in connection with Parkinson's disease].
    Ohta S
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1504-6. PubMed ID: 2698297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes.
    Suzuki T; Fujita S; Narimatsu S; Masubuchi Y; Tachibana M; Ohta S; Hirobe M
    FASEB J; 1992 Jan; 6(2):771-6. PubMed ID: 1537468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease.
    Makino Y; Ohta S; Tachikawa O; Hirobe M
    Life Sci; 1988; 43(4):373-8. PubMed ID: 3398705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry.
    Niwa T; Takeda N; Tatematsu A; Matsuura S; Yoshida M; Nagatsu T
    J Chromatogr; 1988 Oct; 452():85-91. PubMed ID: 3149649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
    Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M
    Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of 1,2,3,4-tetrahydroisoquinoline with some components of cigarette smoke: potential implications for Parkinson's Disease.
    Soto-Otero R; Riguera-Vega R; Méndez-Alvarez E; Sánchez-Sellero I; López-Rivadulla Lamas M
    Biochem Biophys Res Commun; 1996 May; 222(2):607-11. PubMed ID: 8670252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of 1-methyl 1,2,3,4-tetrahydroisoquinoline level in substantia nigra of the aged rat.
    Ayala A; Parrado J; Cano J; Machado A
    Brain Res; 1994 Feb; 638(1-2):334-6. PubMed ID: 8199872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain.
    Yamakawa T; Kotake Y; Fujitani M; Shintani H; Makino Y; Ohta S
    Neurosci Lett; 1999 Nov; 276(1):68-70. PubMed ID: 10586977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke.
    Soto-Otero R; Méndez-Alvarez E; Sánchez-Sellero I; Cruz-Landeira A; López-Rivadulla Lamas M
    Neurosci Lett; 2001 Feb; 298(3):187-90. PubMed ID: 11165438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal modelling of human polymorphic drug oxidation--the metabolism of debrisoquine and phenacetin in rat inbred strains.
    Al-Dabbagh SG; Idle JR; Smith RL
    J Pharm Pharmacol; 1981 Mar; 33(3):161-4. PubMed ID: 6116757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tetrahydroisoquinoline (TIQ), one of endogenous substances inducing parkinsonism, on isolated rat vas deferens.
    Koike K; Takayanagi I; Wani S; Yanagita T; Ohta S; Hirobe M
    Gen Pharmacol; 1989; 20(2):259-60. PubMed ID: 2714622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains.
    Niwa T; Takeda N; Kaneda N; Hashizume Y; Nagatsu T
    Biochem Biophys Res Commun; 1987 Apr; 144(2):1084-9. PubMed ID: 3579928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hydroxylation of debrisoquin in Parkinson's disease].
    Meillard MN; Bentué-Ferrer D; Brunet-Bourgin F; Morel G; Allain H
    Presse Med; 1990 May; 19(20):947-9. PubMed ID: 2141131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of noradrenergic system in the mechanism of action of endogenous neurotoxin 1,2,3,4-tetrahydroisoquinoline: biochemical and functional studies.
    Michaluk J; Krygowska-Wajs A; Karolewicz B; Antkiewicz-Michaluk L
    Pol J Pharmacol; 2002; 54(1):19-25. PubMed ID: 12020040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.
    Tasaki Y; Makino Y; Ohta S; Hirobe M
    J Neurochem; 1991 Dec; 57(6):1940-3. PubMed ID: 1940911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic ochratoxin A hydroxylation in rat strains phenotyped as poor and extensive metabolizers of debrisoquine.
    Castegnaro M; Bartsch H; Bereziat JC; Arvela P; Michelon J; Broussolle L
    Xenobiotica; 1989 Feb; 19(2):225-30. PubMed ID: 2786290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxylation of debrisoquine using perfused liver isolated from Sprague Dawley and DA rats: comparison with in-vivo results.
    Vincent-Viry M; Deshayes S; Mothe O; Siest G; Galteau MM
    J Pharm Pharmacol; 1988 Oct; 40(10):695-700. PubMed ID: 2907535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat. An animal model of the debrisoquine-type polymorphic oxidation in man.
    Zysset T; Zeugin T; Küpfer A
    Biochem Pharmacol; 1988 Aug; 37(16):3155-60. PubMed ID: 3401246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of 1,2,3,4,-tetrahydroisoquinoline in the brain of male Wistar and Dark Agouti rats.
    Lorenc-Koci E; Wójcikowski J; Kot M; Haduch A; Boksa J; Daniel WA
    Brain Res; 2004 Jan; 996(2):168-79. PubMed ID: 14697494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.